MEASUREMENT OF CIRCULATING MUTATION BURDEN
Recruiting
Observational Study
Breast Carcinoma
Genetic Predisposition to Cancer
BRCA Mutation
cfMB
Mutation Burden
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 30 – 50
- Sex
- Female
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- Centre Francois Baclesse · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cancer-free women with a hereditary predisposition to breast and/or ovarian cancer
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Female participant
* Participant undergoing oncogenetic follow-up at the Centre François Baclesse
* Participant belonging to a pair of related biological siblings
* Within the sibling pair, one participant is a carrier of a hereditary predisposition linked to a BRCA1/2 mutatio…
Contacts